An increase in prescriptions and an ongoing labor crunch have helped contribute to a nationwide shortage of Adderall across the US.
The Food and Drug Administration (FDA) on Wednesday confirmed the shortage of the drug, used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The FDA said Teva, the largest manufacturer, is facing “ongoing intermittent manufacturing delays”.
